We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk’s U.S. Growth Driving Investment, Acquisition Plans
Novo Nordisk’s U.S. Growth Driving Investment, Acquisition Plans
Danish insulin maker Novo Nordisk is expanding its footprint in the U.S., acquiring two privately held biopharmaceutical research companies in Indiana and investing in a new manufacturing plant in North Carolina.